AFT Pharmaceuticals First Half 2023 Earnings: EPS: NZ$0.01 (vs NZ$0.04 in 1H 2022)




  • In Business
  • 2022-11-25 18:09:27Z
  • By Simply Wall St.
 

AFT Pharmaceuticals (NZSE:AFT) First Half 2023 Results

Key Financial Results

  • Revenue: NZ$65.8m (up 18% from 1H 2022).

  • Net income: NZ$1.45m (down 66% from 1H 2022).

  • Profit margin: 2.2% (down from 7.6% in 1H 2022). The decrease in margin was driven by higher expenses.

  • EPS: NZ$0.01 (down from NZ$0.04 in 1H 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

AFT Pharmaceuticals Earnings Insights

Looking ahead, revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Pharmaceuticals industry in Oceania.

Performance of the market in New Zealand.

The company's shares are down 2.4% from a week ago.

Risk Analysis

You should learn about the 1 warning sign we've spotted with AFT Pharmaceuticals.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You'll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here

COMMENTS

More Related News

Philips scraps 6,000 jobs in drive to improve profitability
Philips scraps 6,000 jobs in drive to improve profitability

AMSTERDAM (Reuters) -Dutch health technology company Philips said on Monday it would scrap 6,000 jobs to restore its profitability following a recall of...

FNCB Bancorp Full Year 2022 Earnings: EPS: US$1.04 (vs US$1.06 in FY 2021)
FNCB Bancorp Full Year 2022 Earnings: EPS: US$1.04 (vs US$1.06 in FY 2021)

FNCB Bancorp ( NASDAQ:FNCB ) Full Year 2022 Results Key Financial Results Revenue: US$60.1m (up 6.0% from FY 2021). Net...

Veritex Holdings Full Year 2022 Earnings: EPS Misses Expectations
Veritex Holdings Full Year 2022 Earnings: EPS Misses Expectations

Veritex Holdings ( NASDAQ:VBTX ) Full Year 2022 Results Key Financial Results Revenue: US$389.7m (up 13% from FY 2021...

BankFinancial Full Year 2022 Earnings: EPS: US$0.80 (vs US$0.53 in FY 2021)
BankFinancial Full Year 2022 Earnings: EPS: US$0.80 (vs US$0.53 in FY 2021)

BankFinancial ( NASDAQ:BFIN ) Full Year 2022 Results Key Financial Results Revenue: US$55.0m (up 8.4% from FY 2021...

Just Kitchen Holdings Full Year 2022 Earnings: CA$0.23 loss per share (vs CA$0.21 loss in FY 2021)
Just Kitchen Holdings Full Year 2022 Earnings: CA$0.23 loss per share (vs CA$0.21 loss in FY 2021)

Just Kitchen Holdings ( CVE:JK ) Full Year 2022 Results Key Financial Results Revenue: CA$19.0m (up 59% from FY 2021...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business